Clinical Trials Logo

Hyperthermia clinical trials

View clinical trials related to Hyperthermia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05710978 Withdrawn - Hyperthermia Clinical Trials

Biomarkers to Assess Acute Kidney Injury Risk During Heat Strain

Start date: October 13, 2022
Phase: N/A
Study type: Interventional

Prolonged, high intensity work in a hot environment results in significant strain on the body, known as heat strain. Heat strain in hot occupational settings such as agriculture, fire suppression, and military work can lead to ~20% of workers exceeding the glomerular filtration rate indicated thresholds for acute kidney injury (AKI). However, it is unclear whether these individuals truly experienced AKI or if these were normal, healthy physiologic responses. To better determine if AKI occurs in the staggering number of workers previously reported, AKI biomarkers are needed in addition to kidney function markers (e.g., glomerular filtration rate) to characterize this response. The product of urinary tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin-like growth factor binding protein 7 (IGFBP7) is a promising Food and Drug Administration approved biomarker indicating risk of AKI and is currently used in hospitalized individuals. The usefulness of this biomarker in determining AKI in healthy individuals during heat strain is now beginning to be understood. Consecutive days of heat strain can result in repeated AKI, which is hypothesized to lead to chronic kidney disease. There is an epidemic of chronic kidney disease of non-traditional causes occurring in workers who undergo repeated days heat strain, including approximately 15% of outdoor workers in Central America. Of the few studies that investigated consecutive days of work in the heat, we demonstrated that participants exceed the glomerular filtration rate indicated threshold for AKI during consecutive days of heat strain. This project will determine whether [TIMP-2 x IGFBP7] increases during occupational relevant heat exposures in a healthy, active population. Additionally, this project will compare the impact of repeated exposures to a hot environment on risk of AKI.

NCT ID: NCT05640310 Withdrawn - Healthy Clinical Trials

Prospective Study to Validate the Clinical Accuracy of Norbert Device to Measure Body Temperature

Start date: March 2023
Phase:
Study type: Observational

The study will evaluate the clinical bias and clinical repeatability of measuring body temperature using the Norbert Device (ND).

NCT ID: NCT05474352 Withdrawn - Clinical trials for Hyperthermic Intraperitoneal

Use of Water Warming/Cooling Garment to Maintain a Constant Intraoperative Core Target Temperature in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Proof-of-Concept Study

Start date: June 14, 2022
Phase: Early Phase 1
Study type: Interventional

To look at the feasibility of using a water warming/cooling garment (called the ALLON system) to maintain a target body temperature during surgery and chemotherapy perfusion (a method of pouring chemotherapy throughout your abdominal cavity) without overheating or overcooling your body.

NCT ID: NCT04961151 Withdrawn - Sepsis Clinical Trials

Working Toward the Advancement of Recovery Using Modulated Therapeutic Hyperthermia (WARMTH) in Sepsis - Pilot

WARMTH
Start date: August 25, 2021
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to demonstrate the ability to warm critically ill patients with sepsis to a target temperature of 39°C

NCT ID: NCT04698057 Withdrawn - Febrile Neutropenia Clinical Trials

Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial.

ACACIA
Start date: March 1, 2022
Phase: Phase 3
Study type: Interventional

In low risk neutropenic fever in cancer, standard of care is the association of amoxicillin clavulanate and ciprofloxacin. But in this population, the rate of fever related to infection is very low, leading to a overtreatment of the patients. The aim of this study is to validate a descalation of the antibiotherapy with safety concerns.

NCT ID: NCT04257266 Withdrawn - Hyperthermia Clinical Trials

Cryo Pack Cooling After Exercise-induced Hyperthermia

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This research study aims to examine whether Cryo Cooling packs reduce thermal and cardiovascular strain after exercise-induced hyperthermia compared to a commercially available ice pack. Secondly, the effect of Cryo Cooling packs on cognitive and exercise performance will be examined. There is no current research examining the efficacy of Cryo Cooling packs in hyperthermic individuals and this information will be helpful to establish whether Cryo Cooling Packs can be used for performance enhancement or to prevent heat illness.

NCT ID: NCT02561598 Withdrawn - Clinical trials for Malignant Hyperthermia

A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia

Start date: May 2023
Phase:
Study type: Observational

The purpose of the study is to develop methods to identify predictors of Malignant Hyperthermia.